An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial

A Tran-Duy; M Ghiti Moghadam; M Voshaar; HE Vonkeman; A Boonen; P Clarke; G McColl; PM ten Klooster; TR Zijlstra; WF Lems; N Riyazi; EN Griep; Mieke Hazes; R Landewe; HJ Bernelot Moens; P van Riel; M Laar; TL Jansen

doi:10.1002/art.40546

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial

A Tran-Duy, M Ghiti Moghadam, M Voshaar, HE Vonkeman, A Boonen, P Clarke, G McColl, PM ten Klooster, TR Zijlstra, WF Lems, N Riyazi, EN Griep, Mieke Hazes, R Landewe, HJ Bernelot Moens, P van Riel, M Laar, TL Jansen

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1557-1564
Number of pages	8
Journal	ARTHRITIS & RHEUMATOLOGY
Volume	70
Issue number	10
DOIs	https://doi.org/10.1002/art.40546
Publication status	Published - 2018

Access to Document

10.1002/art.40546

http://hdl.handle.net/1765/110025

Cite this

Tran-Duy, A., Ghiti Moghadam, M., Voshaar, M., Vonkeman, HE., Boonen, A., Clarke, P., McColl, G., ten Klooster, PM., Zijlstra, TR., Lems, WF., Riyazi, N., Griep, EN., Hazes, M., Landewe, R., Bernelot Moens, HJ., van Riel, P., Laar, M., & Jansen, TL. (2018). An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial. ARTHRITIS & RHEUMATOLOGY, 70(10), 1557-1564. https://doi.org/10.1002/art.40546

Tran-Duy, A ; Ghiti Moghadam, M ; Voshaar, M ; Vonkeman, HE ; Boonen, A ; Clarke, P ; McColl, G ; ten Klooster, PM ; Zijlstra, TR ; Lems, WF ; Riyazi, N ; Griep, EN ; Hazes, Mieke ; Landewe, R ; Bernelot Moens, HJ ; van Riel, P ; Laar, M ; Jansen, TL. / An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial. In: ARTHRITIS & RHEUMATOLOGY. 2018 ; Vol. 70, No. 10. pp. 1557-1564.

@article{d12fd81fe2384fc7883abec8315ae1c7,

title = "An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial",

author = "A Tran-Duy and {Ghiti Moghadam}, M and M Voshaar and HE Vonkeman and A Boonen and P Clarke and G McColl and {ten Klooster}, PM and TR Zijlstra and WF Lems and N Riyazi and EN Griep and Mieke Hazes and R Landewe and {Bernelot Moens}, HJ and {van Riel}, P and M Laar and TL Jansen",

year = "2018",

doi = "10.1002/art.40546",

language = "Undefined/Unknown",

volume = "70",

pages = "1557--1564",

number = "10",

}

Tran-Duy, A, Ghiti Moghadam, M, Voshaar, M, Vonkeman, HE, Boonen, A, Clarke, P, McColl, G, ten Klooster, PM, Zijlstra, TR, Lems, WF, Riyazi, N, Griep, EN, Hazes, M, Landewe, R, Bernelot Moens, HJ, van Riel, P, Laar, M & Jansen, TL 2018, 'An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial', ARTHRITIS & RHEUMATOLOGY, vol. 70, no. 10, pp. 1557-1564. https://doi.org/10.1002/art.40546

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial. / Tran-Duy, A; Ghiti Moghadam, M; Voshaar, M; Vonkeman, HE; Boonen, A; Clarke, P; McColl, G; ten Klooster, PM; Zijlstra, TR; Lems, WF; Riyazi, N; Griep, EN; Hazes, Mieke; Landewe, R; Bernelot Moens, HJ; van Riel, P; Laar, M; Jansen, TL.

In: ARTHRITIS & RHEUMATOLOGY, Vol. 70, No. 10, 2018, p. 1557-1564.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial

AU - Tran-Duy, A

AU - Ghiti Moghadam, M

AU - Voshaar, M

AU - Vonkeman, HE

AU - Boonen, A

AU - Clarke, P

AU - McColl, G

AU - ten Klooster, PM

AU - Zijlstra, TR

AU - Lems, WF

AU - Riyazi, N

AU - Griep, EN

AU - Hazes, Mieke

AU - Landewe, R

AU - Bernelot Moens, HJ

AU - van Riel, P

AU - Laar, M

AU - Jansen, TL

PY - 2018

Y1 - 2018

U2 - 10.1002/art.40546

DO - 10.1002/art.40546

M3 - Article

VL - 70

SP - 1557

EP - 1564

IS - 10

ER -

Tran-Duy A, Ghiti Moghadam M, Voshaar M, Vonkeman HE, Boonen A, Clarke P et al. An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial. ARTHRITIS & RHEUMATOLOGY. 2018;70(10):1557-1564. https://doi.org/10.1002/art.40546